In another COVID development, the FDA pulled its EUA for Evusheld, the last available monoclonal antibody treatment, due to weak activity against the newer circulating subvariants.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
One day after the United States said it would allow intradermal, fractional dosing of Bavarian Nordic's monkeypox vaccine, Jynneos, the World Health Organization (WHO) called for more trials on the practice.
A systematic review and meta-analysis published yesterday in BMJ estimates that 5.6% of COVID-19 survivors may face long-lasting changes to their sense of smell or taste, adding to concerns about the overall burden of long COVID.
High estimated blood viscosity (eBV) is significantly associated with greater risk of death from complications among hospitalized COVID-19 patients, suggests a retrospective study published yesterday in the Journal of the American College of Cardiology.
A study yesterday in the Journal of Virology suggests that, while co-infection with influenza A and SARS-CoV-2 does not change the trajectory of influenza A, contracting influenza A first could suppress any COVID-19 infection caused by SARS-CoV-2.
Flu activity is rising in some of the Southern Hemisphere's temperate countries, including Australia, New Zealand, and southern Africa. At the global level, however, levels are declining following a March peak, the World Health Organization (WHO) said in a global flu update that roughly covers the first half of June.
Other areas seeing rises are Chile and southern China, where H3N2 is the dominant strain.
In a global flu update that covers the last half of May, the World Health Organization (WHO) said this week that overall activity has declined since a March peak, but levels are rising in some temperate Southern Hemisphere countries, including Australia.
Flu levels are up sharply in some Australian states, putting pressure on healthcare systems that are also coping with ongoing COVID-19 activity and prompting more efforts to get more people vaccinated against flu.
The Democratic Republic of the Congo (DRC) has reported one more Ebola case in its latest outbreak in Equateur province in the country's northwest, raising the total to three, according to the World Health Organization (WHO) African regional office.
Adults hospitalized early in the pandemic with COVID-19 were at more than triple the risk of death than those with influenza, despite the flu patients being older and having more chronic illnesses, according to new data from Spain to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which starts tomorrow.
Four states, including hard-hit Minnesota, reported more highly pathogenic avian flu outbreaks, pushing the nation's poultry losses to more than 28.8 million birds from 29 states.
